Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer. (Q45950196)
scientific article published on 20 April 2009
Language:
(P31) (Q13442814)
(Q45182324)
(P50) (Q94702986)
(P304) 2516-2522
(P407) (Q1860)
(P433) 15
(P478) 27
(P577) Monday, April 20, 2009
(P921) (Q79460)
(Q423762)
(Q415588)
(P1433) (Q400292)
(P1476) "Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer." (language: en)
(P2093) Daniel D Karp
Luis G Paz-Ares
Silvia Novello
Paul Haluska
Linda Garland
Felipe Cardenal
L Johnetta Blakely
Peter D Eisenberg
Corey J Langer
Faye M Johnson
Stephanie Green
Antonio Gualberto
(P2860) (Q44119188)
(Q44683360)
(Q24806159)
(Q46603167)
(Q59405745)
(Q71644034)
(Q50537419)
(Q36720689)
(Q70469484)
(Q46365836)
(Q38465535)
(Q46972238)
(Q28278736)
(Q52560904)
(Q40138493)
(Q51789005)
(Q38305393)
(Q29620301)
(Q36720694)
(Q28251235)
(Q34757952)
(Q34323659)
(Q46604166)
(Q28271304)
(Q46412217)
(P5824) (Q49020911)
other details
description scientific article published on 20 April 2009

External Links